The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,820.00
Bid: 1,822.00
Ask: 1,826.00
Change: -4.00 (-0.22%)
Spread: 4.00 (0.22%)
Open: 1,800.00
High: 1,868.00
Low: 1,800.00
Prev. Close: 1,824.00
GNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

15 Nov 2018 16:00

RNS Number : 5250H
Genus PLC
15 November 2018
 

 

Genus plc (the 'Company') - 2018 AGM Poll Results

 

The Company announces that at its AGM held on Thursday, 15 November 2018, all resolutions set out in the Notice of AGM were passed on a poll. 

 

Resolutions 1 to 13 were passed as Ordinary Resolutions and Resolutions 14 to 17 were passed as Special Resolutions. The following table sets out the votes cast on each resolution: 

 

1. To receive the Company's audited Financial Statements and the Directors' Reports for the year ended 30 June 2018.

41,562,922

99.63

155,211

0.37

925,023

41,718,133

2. To approve the Directors' Remuneration Report for the year ended 30 June 2018.

26,732,450

67.93

12,621,755

32.07

3,288,952

39,354,205

3. To declare a final dividend of 17.9 pence per Ordinary Share.

42,641,974

100.00

588

0.00

595

42,642,562

4. To re-elect Bob Lawson as a Director of the Company.

36,048,529

93.32

2,581,420

6.68

4,013,207

38,629,949

5. To re-elect Karim Bitar as a Director of the Company.

42,313,095

99.23

328,680

0.77

1,382

42,641,775

6. To re-elect Stephen Wilson as a Director of the Company.

42,495,775

99.66

145,127

0.34

2,255

42,640,902

7. To re-elect Lysanne Gray as a Director of the Company.

40,256,875

94.41

2,384,900

5.59

1,382

42,641,775

8. To re-elect Lykele van der Broek as a Director of the Company.

40,284,175

94.47

2,357,600

5.53

1,382

42,641,775

9. To elect Lesley Knox as a Director of the Company.

42,192,946

99.66

142,967

0.34

307,242

42,335,913

10. To elect Ian Charles as a Director of the Company.

42,619,061

99.95

19,891

0.05

4,205

42,638,952

11. To re-appoint Deloitte LLP as auditor of the Company.

41,461,219

97.23

1,179,846

2.77

2,091

42,641,065

12. To authorise the Audit Committee of the Board to determine the remuneration of the auditor.

41,881,907

98.23

755,811

1.77

5,439

42,637,718

13. To empower the Directors with limited authority to allot Ordinary Shares.

38,146,650

90.12

4,183,473

9.88

313,032

42,330,123

14. To empower the Directors with limited authority to allot equity securities for cash without first offering them to existing shareholders.

42,586,646

99.92

34,798

0.08

21,713

42,621,444

15. To empower the Directors with limited authority to allot additional equity securities for cash without first offering them to existing shareholders provided that this power be used only in connection with an acquisition or other capital investment.

36,895,601

86.56

5,726,769

13.44

20,786

42,622,370

16. To empower the Directors with limited authority to make one or more market purchases of any Ordinary Shares.

42,108,111

98.96

442,733

1.04

92,312

42,550,844

17. To allow a General Meeting other than an Annual General Meeting to be called on not less than 14 clear days' notice.

40,457,388

94.89

2,178,463

5.11

7,306

42,635,851

 

 

 

A copy of the special business resolutions will be submitted to the National Storage Mechanism and will soon be available to view at http://www.morningstar.co.uk/uk/NSM.

As at the close of business on 14 November 2018, the total number of ordinary shares of £0.10 each eligible to be voted at the AGM was 61,948,505. Therefore, the total voting rights in the Company as at that time were 61,948,505.

Equiniti acted as scrutineer of the poll on all resolutions.

 

Senior Independent Director and Chairman of the Remuneration Committee

 

The Company is pleased to announce that Lesley Knox, Non-Executive Director (appointed June 2018) has been appointed Senior Independent Non-Executive Director and Chairman of the Remuneration Committee, effective immediately. This follows the retirement of Nigel Turner at the AGM earlier today and as previously announced on 24 September 2018. This statement is made in accordance with Listing Rule 9.6.11.

 

AGM - Resolution Two

 

The Board of Genus acknowledges that a number of votes were received from shareholders against Resolution 2, for the approval of the Directors Remuneration Report ("DRR"). It is evident through the feedback that votes against the Resolution were predominantly linked to the one-off adjustment to the CEO salary, which was determined by our Remuneration Committee ("Committee") and for which a detailed justification was made in the DRR.

The Company actively engaged with our top ten shareholders to discuss this change ahead of the publication of the Annual Report and DRR to address any potential concerns.

 

We are aware that reports from a number of shareholder agencies recommended voting against Resolution 2. We were disappointed with these recommendations. The change in CEO salary was designed as a one-off intervention that the Committee believed was both justified and necessary to retain and motivate a very high calibre leader who is steering the transformation of the business, creating significant long-term stakeholder value, and setting the future strategic direction of the Company as it transforms into an agricultural biotechnology pioneer.

 

The Board and Committee take seriously their responsibilities to represent the interests of shareholders and to uphold the highest standards of corporate governance. Our existing Remuneration Policy received strong levels of shareholder support when approved in 2016, and we will put a new Remuneration Policy to shareholders at our 2019 AGM. Ahead of this we will also continue to engage with shareholders on reward, and to consider their views on our existing policy, including the shareholder views being expressed in relation to Resolution 2.

 

Bob Lawson, Chairman of Genus said: "We believe that Karim Bitar's one-off salary realignment is in the best interests of the Company and the justification is clear. The Remuneration Committee takes a highly responsible approach to executive pay and, to date, has enjoyed strong support from our shareholders."

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RAGGGGMAGUPRGCA
Date   Source Headline
9th Jun 20177:00 amRNSUS LITIGATION UPDATE
2nd Jun 20177:00 amRNSTotal Voting Rights
1st Jun 20177:05 amRNSUpdate Regarding The Milk Pension Fund
2nd May 20173:00 pmRNSTotal Voting Rights
12th Apr 20174:48 pmRNSDirector/PDMR Shareholding
3rd Apr 20172:00 pmRNSTotal Voting Rights
3rd Apr 20177:00 amRNSSUCCESSFUL LEGAL OUTCOME FOR GENUS
15th Mar 20175:15 pmRNSDirector/PDMR Shareholding
15th Mar 201712:00 pmRNSDirector Declaration
1st Mar 201710:09 amRNSDirector/PDMR Shareholding
23rd Feb 20174:20 pmRNSCorrection of Record Date
23rd Feb 20177:00 amRNSInterim Results
23rd Feb 20177:00 amRNSAcquisition and strategic partnership
7th Feb 20174:00 pmRNSHolding(s) in Company
1st Feb 20172:00 pmRNSBlock listing Interim Review
13th Dec 20163:39 pmRNSDirector/PDMR Shareholding
1st Dec 20162:00 pmRNSTotal Voting Rights
17th Nov 20162:01 pmRNSResult of AGM
17th Nov 20167:00 amRNSAGM - Trading Update
1st Nov 20164:00 pmRNSTotal Voting Rights
31st Oct 20163:47 pmRNSAnnual Report and Annual General Meeting
26th Oct 20164:00 pmRNSHolding(s) in Company
11th Oct 20164:08 pmRNSDirector/PDMR Shareholding
3rd Oct 20166:09 pmRNSBlock Listing and Additional Listing
3rd Oct 20165:57 pmRNSTotal Voting Rights
29th Sep 20165:00 pmRNSDirector/PDMR Shareholding
15th Sep 20165:00 pmRNSDirector/PDMR Shareholding
8th Sep 20165:18 pmRNSDirector/PDMR Shareholding
8th Sep 20167:00 amRNSPreliminary Results
7th Sep 20167:00 amRNSNON-EXECUTIVE DIRECTOR RETIREMENT
1st Sep 20164:17 pmRNSTotal Voting Rights
15th Aug 20167:00 amRNSFINAL JURY DECISIONS IN US LITIGATION
12th Aug 20167:00 amRNSFURTHER DECISIONS IN US LITIGATION
11th Aug 20167:00 amRNSFIRST DECISIONS IN US ANTI-TRUST LITIGATION
1st Aug 20169:20 amRNSBlock listing Interim Review
1st Aug 20169:09 amRNSTotal Voting Rights
27th Jul 20167:00 amRNSSigns exclusive licence for tech. to combat BRD
15th Jul 20167:00 amRNSAdoption of Financial Reporting Standard (FRS) 101
1st Jul 20163:10 pmRNSTotal Voting Rights
17th Jun 20164:40 pmRNSSecond Price Monitoring Extn
17th Jun 20164:35 pmRNSPrice Monitoring Extension
1st Jun 20162:00 pmRNSTotal Voting Rights
18th May 20167:00 amRNSExclusive Licence for Leading Gene Editing Tech
3rd May 20162:29 pmRNSTotal Voting Rights
13th Apr 20163:13 pmRNSDirector/PDMR Shareholding
1st Apr 20163:31 pmRNSDirector/PDMR Shareholding
9th Mar 20165:03 pmRNSDirector/PDMR Shareholding
4th Mar 20169:30 amRNSBOARD APPOINTMENT
3rd Mar 20162:00 pmRNSDirector/PDMR Shareholding
1st Mar 20165:17 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.